Literature DB >> 25395464

MGMT methylation in glioblastoma: tale of the tail.

Nameeta Shah1, Brett Schroeder1, Charles Cobbs1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25395464      PMCID： PMC4483058          DOI： 10.1093/neuonc/nou319

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  5 in total

1.  MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors:  Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

2.  Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.

Authors:  Mark R Gilbert; Meihua Wang; Kenneth D Aldape; Roger Stupp; Monika E Hegi; Kurt A Jaeckle; Terri S Armstrong; Jeffrey S Wefel; Minhee Won; Deborah T Blumenthal; Anita Mahajan; Christopher J Schultz; Sara Erridge; Brigitta Baumert; Kristen I Hopkins; Tzahala Tzuk-Shina; Paul D Brown; Arnab Chakravarti; Walter J Curran; Minesh P Mehta
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

3.  MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas.

Authors:  Judith W M Jeuken; Sandra J B Cornelissen; Martine Vriezen; Marieke M G Dekkers; Abdellatif Errami; Angelique Sijben; Sandra H E Boots-Sprenger; Pieter Wesseling
Journal:  Lab Invest       Date:  2007-08-13       Impact factor: 5.662

4.  Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma.

Authors:  Ilse Vlassenbroeck; Stéphane Califice; Annie-Claire Diserens; Eugenia Migliavacca; Josef Straub; Ivano Di Stefano; Fabrice Moreau; Marie-France Hamou; Isabelle Renard; Mauro Delorenzi; Bruno Flamion; James DiGuiseppi; Katja Bierau; Monika E Hegi
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568

5.  Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBM.

Authors:  Nameeta Shah; Biaoyang Lin; Zita Sibenaller; Timothy Ryken; Hwahyung Lee; Jae-Geun Yoon; Steven Rostad; Greg Foltz
Journal:  PLoS One       Date:  2011-01-07       Impact factor: 3.240
  5 in total
  5 in total

1.  The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?

Authors:  Alyssa M Vanderbeek; Rifaquat Rahman; Geoffrey Fell; Steffen Ventz; Tianqi Chen; Robert Redd; Giovanni Parmigiani; Timothy F Cloughesy; Patrick Y Wen; Lorenzo Trippa; Brian M Alexander
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

2.  The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells.

Authors:  Paul A Clark; Jordan T Gaal; Joslyn K Strebe; Cheri A Pasch; Dustin A Deming; John S Kuo; H Ian Robins
Journal:  J Clin Neurosci       Date:  2016-11-16       Impact factor: 1.961

3.  Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor.

Authors:  Uros Smrdel; Mara Popovic; Matjaz Zwitter; Emanuela Bostjancic; Andrej Zupan; Viljem Kovac; Damjan Glavac; Drago Bokal; Janja Jerebic
Journal:  Radiol Oncol       Date:  2016-11-10       Impact factor: 2.991

4.  Tumor Treating Fields (TTFields) therapy vs physicians' choice standard-of-care treatment in patients with recurrent glioblastoma: a post-approval registry study (EF-19).

Authors:  Jay-Jiguang Zhu; Samuel A Goldlust; Lawrence R Kleinberg; Jérôme Honnorat; Nancy Ann Oberheim Bush; Zvi Ram
Journal:  Discov Oncol       Date:  2022-10-14

Review 5.  Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance.

Authors:  Silvia Valtorta; Daniela Salvatore; Paolo Rainone; Sara Belloli; Gloria Bertoli; Rosa Maria Moresco
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.